Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kohsaku Ohnishi"'
Autor:
Atsushi Hosui, Takashi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu
Publikováno v:
Hepatology Communications, Vol 5, Iss 12, Pp 2001-2008 (2021)
We have reported that the plasma zinc concentration gradually decreases with the progression of fibrosis and is related to hepatocellular carcinoma (HCC) development. The aim of this study was to examine the impact of the zinc concentration on HCC de
Externí odkaz:
https://doaj.org/article/23a7b131d71d4caa81c6716491de355b
Autor:
Seiichi Goda, Chikato Koga, Kohsaku Ohnishi, Masanori Tsujie, Mitsuyoshi Tei, Ryohei Kawabata, Junichi Hasegawa, Masaki Wakasugi
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Jejunal varices should be included in the differential diagnosis of melena in patients with a bilioenteric anastomosis and portal vein hypertension. • Laparotomy-assisted transcatheter variceal embolization is one of the options for
Autor:
Motohiro Hirao, Atsushi Hosui, Akihiro Mimura, Kohsaku Ohnishi, Takashi Tanimoto, Toru Okahara, Yuka Sueyoshi, Takayoshi Goto, Takuya Yamada, Naoki Hiramatsu
Publikováno v:
Photodiagnosis and photodynamic therapy. 38
For the early diagnosis of malignant biliary stricture due to biliary-pancreatic carcinoma, conventional biliary brush cytology with endoscopic retrograde cholangiopancreatography (ERCP; the conventional method) is not sensitive enough.Two hundred ni
Autor:
Yuhhei Wakahara, Takuya Yamada, Takafumi Tanimoto, Atsushi Hosui, Toru Okahara, Toshio Yamaguchi, Kohsaku Ohnishi, Yuka Sueyoshi, Motohiro Hirao, Yukihiro Kusumoto, Naoki Hiramatsu, Munehiro Ashida
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 2
Journal of Clinical Medicine, Vol 10, Iss 294, p 294 (2021)
Volume 10
Issue 2
Journal of Clinical Medicine, Vol 10, Iss 294, p 294 (2021)
(1) Backgrounds and aim: Tolvaptan, a selective vasopressin type 2 receptor antagonist, was approved for ascites, and its short-term efficacy and safety have been confirmed. However, it is still unclear whether this novel drug may improve long-term s
Autor:
Shinya Kimura, Toshihiro Funatsu, Satoshi Kainuma, Kengo Matsumoto, Kohsaku Ohnishi, Shinnosuke Kudo, Makoto Fukuoka, Motohiro Hirao, Yukihiro Kusumoto, Kumiko Shirai, Yuka Sueyoshi, Atsushi Housui, Kazuhiro Taniguchi, Kazuki Maesaka, Masato Komori, Masahiko Tsujii, Naoki Okuyama
Publikováno v:
Pancreatology. 16:S166